Quantum BioPharma is trading 5.32% higher at $2.97, with no clear company-specific catalyst identified for the October 13 move.
- A summit announcement appearing in today’s search results was originally issued September 15, so it is not new.
- The Thermo Fisher trial agreement was announced October 6.
- The biotech sector was weak, with XBI down 2.01%; broader indices were also modestly lower, which does not explain the gain.